Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions

Bone Marrow Transplantation

Volumn 18, Issue 6, 1996, Pages 1179-1181

  Ljungman, P ^a   Lawler, M ^b   Lonnqvist B ^a   Ringden O ^a   Shanwell, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Aplastic anemia; Donor lymphocytes; Rejection

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CASE REPORT; GRAFT REJECTION; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFUSION; MALE; MORTALITY; PRIORITY JOURNAL; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION; TANDEM REPEAT;

ADULT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; ERYTHROPOIETIN; GRAFT REJECTION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE TRANSFUSION; MALE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030457482     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Storb R, Thomas ED, Weiden PL et al. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood 1976; 48: 817-841.
2. Bacigalupo A, Hows J, Gluckman E et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report on the EBMT SAA working party. Br J Haematol 1988; 70: 177-182.
3. Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994; 84: 941-949.
4. Deeg HJ, Self S, Storb R et al. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. Blood 1986; 68: 1363-1368.
5. Storb R, Weiden PL, Sullivan KM et al. Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood 1987; 70: 116-121.
6. McCann S, Bacigalupo A, Gluckman E et al. Graft rejection and second bone marrow transplants for acquired aplastic anemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 1994; 13: 233-238.
7. Kolb H, Mittermüller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
8. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041-2050.
9. Browne PV, Lawler M, Humphries P, McCann SR. Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. New Engl J Med 1991; 325: 710-713.
10. Riddell SR, Watanabe KS, Goodrich JM et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992; 257: 238-241.